Synopsys executive chair Aart de Geus sells $11.1m in stock
Synopsys executive chair Aart de Geus sold shares worth $11.1 million on August 28, 2026, exercising his right under a Rule 10b5-1 trading plan. The sale took place at prices between $440.985 and $461.850, averaging a sale price of $445.5502. Concurrently, de Geus purchased 25,000 shares using non-qualified stock options, paying $3.397 million.
Post-transaction, he owns 120,421 shares directly, 308,791 indirectly through family trusts, and 14,500 indirectly through partnerships, along with 49,641 stock options. Synopsys boasts gross profit margins of 83%, and is viewed as undervalued by InvestingPro’s Fair Value analysis. The company reported Q3 2026 results beating estimates, with non-GAAP earnings of $3.91 per share and revenue of $2.48 billion, surpassing Wall Street's forecasts.
Boosted by this success, Synopsys raised its full-year guidance. Benchmark and Baird analysts have raised their ratings for Synopsys, citing positive growth expectations.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
